Bayer Launches Corporate Campaign Highlighting Scientific Breakthroughs

Bayer Launches “Science Delivers” Campaign to Combat Misinformation

In an era where scientific skepticism and misinformation continue to gain traction, pharmaceutical giant Bayer has unveiled a new corporate initiative aimed at reaffirming the importance of scientific progress in everyday American life.

The “Science Delivers” campaign, which debuted on World Science Day this week, represents a comprehensive push across multiple platforms to highlight the tangible ways science impacts communities nationwide. The initiative includes nationally broadcast advertisements, an informational website, a published declaration in major publications, and interactive public installations.

The centerpiece of the campaign is a minute-long video that showcases diverse Americans in various settings while a narrator emphasizes how science provides “hope to the diagnosed, clean water to our communities, energy to our neighborhoods,” along with agricultural innovations that help “farmers grow more with less” while protecting land resources.

“Science delivers more than solutions, it delivers breakthroughs—breakthroughs that heal, protect and connect us,” the advertisement concludes, encouraging continued scientific inquiry and discovery.

To foster public engagement, Bayer has created oversized “Science, Sealed, Delivered” mailboxes that will appear at selected events, beginning with last month’s World Food Prize Foundation gathering in Iowa. These installations invite citizens to share personal testimonials about science’s impact on their lives through digital postcards.

The campaign’s website already hosts more than 130 such entries, with contributors acknowledging science’s role in creating everything from life-saving medications to everyday technologies like GPS and cell phones, and even culinary fundamentals like bread yeast.

Perhaps most notably, the campaign includes a declaration titled “Don’t (Just) Trust the Science” published in the Wall Street Journal, Washington Times, and Politico. The statement emphasizes that legitimate science isn’t built on blind faith but rather on factual evidence, rigorous analysis, peer review, and open debate.

“Misinformation about science can have devastating consequences,” the declaration states, as it calls on scientists, educators, media professionals, and citizens to join Bayer in combating false scientific claims.

The declaration also directly addresses potential skepticism about corporate motivations, with Bayer acknowledging public suspicion of “an ulterior motive” while pledging to “work extra hard” to earn trust and fulfill its stated mission of “Health for All, Hunger for None.”

Bayer’s initiative enters a crowded field of pharmaceutical companies promoting science-focused messaging. Just last week, Sanofi expanded its global campaign highlighting patient and employee stories with the tagline “We chase the miracles of science so you can chase your dreams.”

Other industry players have launched similar efforts in recent years. AstraZeneca continues its established “What science can do” campaign, while AbbVie and Astellas have created their own corporate branding centered on scientific innovation. Pfizer notably invested in a 2024 Super Bowl advertisement titled “Here’s to Science,” following its pandemic-era campaign “Science Will Win.”

The trend reflects growing concern within the pharmaceutical and agricultural sectors about science skepticism and misinformation campaigns that can undermine public health initiatives and evidence-based practices. By humanizing scientific achievements and connecting them to tangible improvements in daily life, these companies hope to rebuild trust in scientific institutions and processes.

For Bayer, whose portfolio spans pharmaceuticals, consumer health products, and agricultural solutions, the “Science Delivers” campaign represents an attempt to unify its diverse business interests under the common theme of science-driven progress while countering growing anti-science sentiment in public discourse.